USPTO serial 79293944
EPI-MINDER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 23, 2021
- Examiner
- MCNAMARA, SHANA MARIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with EPI-MINDER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
AU
AU
AU
AU
AU
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anne Wang
Anne Wang Frost Brown Todd LLP301 East Fourth Street3300 Great American TowerCincinnati, OH 45202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical apparatus and instruments for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; electronic medical apparatus for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; medical diagnostic devices and instruments for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; medical devices and instruments for monitoring and treating health and medical conditions, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; medical implants made of artificial materials for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; wearable medical devices for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; apparatus for use in the diagnosis, monitoring and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; sensors being measurement apparatus for medical use, namely, the monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnoea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics | ACTIVE | — |
| 035 | Collection of medical data into computer databases for business purposes; compilation of medical reports into computer databases for business purposes; data base management, being medical data; data management consultancy, being medical data | ACTIVE | — |
| 042 | Medical research in the field of neurological conditions and central nervous system disorders; medical research in the field of epilepsy; technological research and design in the field of medical devices, apparatus and instruments; technological research and design of computer hardware, firmware and software for use in the medical field; software as a service (SAAS) services featuring software for use in database management and signal analysis for use in the medical field; platforms as a service (PAAS) services featuring computer software platforms for use in database management and signal analysis for use in the medical field; installation, maintenance and repair of computer firmware and computer software for use in the medical field | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Epiminder Limited
- Other trademarks owned by Epi-Minder Pty Ltd
- Other trademarks owned by Epi-Minder Pty Ltd
- Other trademarks owned by Epi-Minder Pty Ltd
- Other trademarks owned by Epi-Minder Pty Ltd
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named EPI-MINDER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 22, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 31, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 31, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 31, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 31, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 31, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 31, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 6, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 12, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 11, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 23, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 23, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 5, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 18, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 18, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 18, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 1, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 23, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 23, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 23, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 23, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 21, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 21, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 21, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 17, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 17, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 17, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 17, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 17, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 17, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 24, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 31, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 31, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 16, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 15, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 3, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 29, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 24, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 17, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |